BioFocus and Activiomics team up to boost drug candidate selection
BioFocus and Activiomics have teamed up to offer a drug discovery and biomarker service which it says will improve the identification of novel targets.
Archives for July 30, 2012
Granules India cites rising China API and intermediates prices as Q1 driver
Granules India saw API sales rocket in the fiscal first quarter due – according to the firm – to an efficiency drive and the impact of rising prices in China.
US Rayos approval good news for Skyepharma says analyst
Reformulation and delivery tech firm SkyPharma is set for an earnings boost following US approval for rheumatoid arthritis (RA) drug developed by Horizon Pharma.
Catalent plans single use overhaul of bioreactors
Catalent has replaced all stainless steel bioreactors at its biologics facility in Middleton, Wisconsin with single-use techs citing cost and flexibility advantages.
Lilly to double insulin capacity by 2017 without adding plants
Eli Lilly plans to double its insulin and device manufacturing capacity by 2017 without building any new production plants.
Ricerca launches two new in vitro assays including cytokine storm test
US Preclinical CRO Ricerca has launched two new assay services one of which is designed to help assess the risk a biologic drug will induce a cytokine storm.
Linde says cryogenic fog can help freeze-dry biologics
Industrial gas supplier Linde claims its 'cryogenic fog' technology is the first commercially-feasible way of controlling ice-crystal formation during the lyophilisation of biologic drugs.